Following its day of glory, with two antibiotics approved for a total of three indications, Paratek (PRTK) didn't waste any time and immediately adopted a "Revenue Performance Incentive Plan."
Incentives are usually a good thing. However, they should be created keeping in mind their ultimate goal – which is to increase per-share value. And unfortunately this is rarely the case.
READ FULL ARTICLE HERE